Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Anju Parthan"'
Publikováno v:
Journal of Osteoporosis, Vol 2015 (2015)
Purpose. To evaluate the cost-effectiveness of denosumab versus other osteoporotic treatments in older men with osteoporosis from a US payer perspective. Methods. A lifetime cohort Markov model previously developed for postmenopausal osteoporosis (PM
Externí odkaz:
https://doaj.org/article/2c819bd5149945ddbd854ee449e187e9
Autor:
Kristi, Jackson, Anju, Parthan, Miranda, Lauher-Charest, Lynne, Broderick, Nancy, Law, Carolina, Barnett
Publikováno v:
Neurology and Therapy. 12:107-128
Patients with generalized myasthenia gravis (gMG) experience functional impairment due to MG symptoms. This study aimed to assess, from the patient perspective, the symptoms, impacts, and treatment goals of individuals diagnosed with gMG.Semi-structu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2c034a91f2ecd1cb8469a2bfb5f201
https://doi.org/10.1007/s40120-022-00408-x
https://doi.org/10.1007/s40120-022-00408-x
Autor:
Daniel Basoff, Anju Parthan, Raj Bandaru, Anusorn Thanataveerat, Matthew Kent, Michael Hehir, Ali A. Habib
Publikováno v:
Sunday, April 23.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2b237f2a45080663012f96456ef45f2
https://doi.org/10.1212/wnl.0000000000202377
https://doi.org/10.1212/wnl.0000000000202377
Autor:
Guillermo Villa, Milton C. Weinstein, Kelly Fust, Qing Gu, Xiaoyan Li, Spiros Tzivelekis, Gary H. Lyman, Michael Maschio, Anju Parthan
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 17:39-52
Introduction: We reviewed the evolution of the methods used in cost-effectiveness analyses of granulocyte colony-stimulating factors (G-CSFs) in the primary and secondary prevention of febrile neutropenia (FN) in patients receiving myelosuppressive c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6ce9ba983b907ea2ac44f12f7f4384b
https://doi.org/10.1080/14737167.2017.1276829
https://doi.org/10.1080/14737167.2017.1276829
Autor:
Kelly, Fust, Anju, Parthan, Xiaoyan, Li, Anjali, Sharma, Xinke, Zhang, Marco, Campioni, Junji, Lin, Xuena, Wang, Richard, Zur, Karynsa, Cetin, Melissa, Eisen, David, Chandler
Publikováno v:
The American journal of managed care. 24(8 Spec)
This analysis estimated the cost per response and the incremental cost per additional responder of romplostim, eltrombopag, and the "watch-and-rescue" (monitoring until rescue therapies are required) strategy in adults with chronic immune thrombocyto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3b0e7294b308e672ad35edfbcd68420a
https://pubmed.ncbi.nlm.nih.gov/30020741
https://pubmed.ncbi.nlm.nih.gov/30020741
Autor:
John P. Caloyeras, Daria B. Crittenden, Claire E O'Hanlon, Richard Barron, Anju Parthan, Yawen Jiang, Morgan Kruse, Shannon Cartier, Björn Stollenwerk
Publikováno v:
Clinical therapeutics. 39(7)
Purpose The goal of this study was to assess and compare the potential clinical and economic value of emerging bone-forming agents using the only currently available agent, teriparatide, as a reference case in patients at high, near-term (imminent, 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e4384959b7fa93cf1e14d7176b4916
https://pubmed.ncbi.nlm.nih.gov/28629610
https://pubmed.ncbi.nlm.nih.gov/28629610
Autor:
Morgan Kruse, Anju Parthan, Hema N. Viswanathan, Nicole Yurgin, Douglas C.A. Taylor, Joice Huang
Publikováno v:
Applied Health Economics and Health Policy. 11:485-497
In the US, 26 % of women aged ≥65 years, and over 50 % of women aged ≥85 years are affected with postmenopausal osteoporosis (PMO). Each year, the total direct health care costs are estimated to be $US12–18 billion. The cost effectiveness of de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e1fd4c16694b2d6b2edccd319d553a2
https://doi.org/10.1007/s40258-013-0047-8
https://doi.org/10.1007/s40258-013-0047-8
Autor:
Marc Paolantonio, Myrlene Sanon, Medha Sasane, John Coombs, Anju Parthan, Douglas C.A. Taylor
Publikováno v:
Journal of Medical Economics. 16:150-159
Recent clinical trial data have demonstrated that 3 years vs 1 year of adjuvant imatinib therapy for patients with surgically resected Kit+ Gastrointestinal Stromal Tumors (GIST) leads to a significant improvement in recurrence-free survival and over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70269af0e3aa4bbffd749d5f2a579e71
https://doi.org/10.3111/13696998.2012.709204
https://doi.org/10.3111/13696998.2012.709204
Publikováno v:
Head & Neck. 31:1255-1262
Background. Trial TAX 324 showed that induction chemotherapy with docetaxel plus cisplatin and 5-fluorouracil (TPF) compared with cisplatin and 5-fluorouracil (PF) followed by chemoradiation increases survival and time to progression in squamous cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a41481dfd21630267b258820ea2be87
https://doi.org/10.1002/hed.21096
https://doi.org/10.1002/hed.21096
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 6:303-314
Fibromyalgia is a complex, chronic condition involving persistent and widespread pain of unknown origin. In the USA the syndrome affects approximately 2% of the population, with prevalence increasing with age, and has a greater predominance in female
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8b4ea0ae6ebc0258614ba78795199fc
https://doi.org/10.1586/14737167.6.3.303
https://doi.org/10.1586/14737167.6.3.303